Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
European Urology|March 17, 2024
Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment?Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al.
BJU International|February 23, 2023
Teaching robotic cystectomy: prospective pilot clinical validation of the ERUS training curriculumRomain Diamand, Frederiek D'Hondt, Georges Mjaess, et al.
Urologic Oncology|May 29, 2026
ISUP 2 prostate cancer with suspicion of extraprostatic extension on MRI: Prostatectomy results and oncologic outcomesNorbert De Brek, Arthur Peyrottes, Romain Diamand, et al.
World Journal of Urology|August 11, 2020
Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemicRomain Diamand, Guillaume Ploussard, Mathieu Roumiguié, et al.
Urologic Oncology|October 12, 2020
Stratifying patients with intermediate-risk prostate cancer: Validation of a new model based on MRI parameters and targeted biopsy and comparison with NCCN and AUA subclassificationsRomain Diamand, Guillaume Ploussard, Mathieu Roumiguié, et al.
European Urology|October 7, 2020
External Validation of a Multiparametric Magnetic Resonance Imaging-based Nomogram for the Prediction of Extracapsular Extension and Seminal Vesicle Invasion in Prostate Cancer Patients Undergoing Radical ProstatectomyRomain Diamand, Guillaume Ploussard, Mathieu Roumiguié, et al.
World Journal of Urology|December 12, 2022
Optimizing multiparametric magnetic resonance imaging-targeted biopsy and prostate cancer grading accuracyRomain Diamand, Alexandre Peltier, Jean-Baptiste Roche, et al.
European Urology Focus|October 9, 2022
Expanding Active Surveillance Criteria for Low- and Intermediate-risk Prostate Cancer: Can We Accurately Predict the Risk of Misclassification for Patients Diagnosed by Multiparametric Magnetic Resonance Imaging-targeted Biopsy?Romain Diamand, Simone Albisinni, Jean-Baptiste Roche, et al.
The Prostate|January 27, 2023
Risk stratification for early biochemical recurrence of prostate cancer in the era of multiparametric magnetic resonance imagining-targeted biopsyRomain Diamand, Alexandre Peltier, Jean-Baptiste Roche, et al.
European Urology Oncology|October 24, 2022
Magnetic Resonance Imaging-based T-staging to Predict Biochemical Recurrence after Radical Prostatectomy: A Step Towards the iTNM ClassificationMichael Baboudjian, Bastien Gondran-Tellier, Alae Touzani, et al.
Pageof 8